PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Through this study, the investigators are to prove that Cilostazol effectively prevent
progression of intima-medial thickness in ischemic stroke patients with high risk of cerebral
hemorrhage, along with no significant increase in the risk of occurrence of hemorrhagic side
effects.
The primary hypothesis of this study is; Cilostazol alone or with probucol will reduce the
progression of intima-medial thickness compared to aspirin in the ischemic stroke patients
with symptomatic or asymptomatic old cerebral hemorrhage.